Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor

Yong-Li Dong1,2, Gangadhara P Vadla3, Jin-Yu Jim Lu1,4

  • 1Howard Hughes Medical Institute, Department of Genetics, Yale University School of Medicine, Boyer Center for Molecular Medicine, New Haven, CT, USA.

Communications Biology
|March 20, 2021
PubMed

Insights

Oncogenic Ras mutations cause radiation resistance. A novel cell-cell communication pathway involving JAK/STAT signaling in the tumor microenvironment (TME) promotes tumor regrowth after radiation, suggesting new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Oncogenic RAS mutations are linked to tumor resistance to radiation therapy.
  • The tumor microenvironment (TME) significantly impacts therapy outcomes, but its role in Ras-driven radioresistance is not fully understood.

Purpose of the Study:

  • To investigate the mechanisms of cell-cell interactions in the TME that contribute to oncogenic Ras tumor radioresistance.
  • To identify potential therapeutic targets for overcoming Ras-driven radioresistance.

Main Methods:

  • Utilized Drosophila oncogenic Ras tissues and human Ras cancer cell radiation models.
  • Investigated the role of p53 activation and JAK/STAT signaling in response to genotoxic stress.
  • Examined the impact of blocking cell-cell communication pathways on tumor radioresistance.

Main Results:

  • Discovered that genotoxic stress and oncogenic Ras cooperate to activate non-cell autonomous JAK/STAT signaling in the TME.
  • Observed heterogeneous p53 activation in irradiated Ras tumor tissues, leading to cytokine stimulation.
  • Demonstrated that blocking this JAK/STAT communication loop re-sensitizes Ras tumors to irradiation.

Conclusions:

  • A novel cell-cell communication loop involving p53 and JAK/STAT signaling drives Ras tumor radioresistance.
  • Targeting this pathway, potentially with STAT inhibitors combined with radiotherapy, could improve treatment outcomes for Ras-driven cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K